We have a different view of what 113 is...it will get breakthrough drug designation....It will be approved under that designation...So let it be Written...So let it be Done....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.